Jun 2026 (Q2 FY26) — Jul 31, 2026
Healthcare Realty Trust Q2 FY26 — Strong Operational Outperformance and Strategic Capital Allocation
Read the full callHealthcare Realty Trust earnings: last reported Fri, 31 Jul 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 282 | −5.3% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | Operating profit / revenue | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Net profit | -43.5 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
1Y: $18.6 on 17 Oct 2025 → $17.24. High $21.87 (28 Jul 2026), low $16.34 (28 Jan 2026).
Overview
Call summaries
Healthcare Realty Trust Q2 FY26 — Strong Operational Outperformance and Strategic Capital Allocation
Read the full callHealthcare Realty Q1 FY26 — Strong Performance Drives Raised Guidance and Strategic Capital Allocation
Read the full callEvery analysed call
Financials
Net profit, year on year: +72% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 315 | 310 | 299 | 298 | 298 | 286 | 279 | 282 |
| Other income | -106 | -107 | -64 | -176 | -83 | -19 | -32 | -83 |
| Interest | 61 | 58 | 55 | 53 | 53 | 48 | 44 | 45 |
| Net profit | -93 | -107 | -45 | -158 | -58 | 14 | -0 | -44 |
| EPS ($ per share) | -0.26 | — | -0.13 | -0.45 | -0.17 | — | 0 | -0.13 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 2 | 2 | 2 | 2 | 4 | 4 | 4 | 4 |
| Total liabilities | 2,847 | 3,208 | 3,556 | 2,074 | 6,168 | 5,714 | 5,345 | 4,534 |
| Total assets | 6,188 | 6,639 | 6,791 | 4,259 | 13,850 | 12,637 | 10,651 | 9,211 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 337 | 340 | 470 | 233 | 273 | 500 | 502 | 457 |
| Cash from investing | 176 | -667 | -555 | -562 | 1,634 | 349 | 901 | 711 |
| Cash from financing | -499 | 231 | 100 | 328 | -1,859 | -884 | -1,359 | -1,211 |
| Net cash flow | 15 | -96 | 15 | -2 | 48 | -35 | 43 | -43 |
| Capital expenditure | -95 | -645 | -472 | -463 | -403 | -49 | 0 | -0 |
| Free cash flow | 242 | -304 | -2 | -230 | -130 | 451 | 502 | 457 |
| Segment | Q1 FY2024 | Q2 FY2024 | Q3 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q1 FY2026 | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Medial Outpatient Properties | — | — | — | 100% | 100% | 100% | 100% | 100% | -5.3% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
| KPI | Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|
| Retention rate | 93.5%During the first quarter, our retention rate was 93.5%.Source: earnings call transcript | 88.5%Tenant retention was a standout at 88.5%, helping drive approximately 25 basis points of absorption and lifting same-store occupancy to nearly 93%.Source: earnings call transcript | -5 pt |
| Capital expenditures Redevelopment portfolio | $25MWe bought back $100 million of stock, we completed in excess of $20 million of acquisitions and we invested $25 million in our redevelopment portfolio.Source: earnings call transcript | ~$25MDuring the quarter, we invested approximately $25 million in this portfolio, and we have leased it up to 67% an improvement of 1,400 basis points over the last 4 quarters.Source: earnings call transcript | — |
| Properties Redevelopment | 23Third, redevelopment, which currently consists of 23 properties that are 64% pre-leased.Source: earnings call transcript | ~25We've got around 25 assets in redevelopment today.Source: earnings call transcript | — |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
42 filings between Dec 4, 2025 and Sep 8, 2026.
Purchases
$181.1K
2 purchases by 2 insiders
Sales
$926.2K
2 sales by 2 insiders
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Callaway Amanda L | — | $524.9K | Jun 23, 2026 |
| Hull Robert E | — | $401.3K | Sep 8, 2026 |
| Bohjalian Thomas N | $180.9K | — | Mar 6, 2026 |
| Gabbay Daniel | $187 | — | Mar 4, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 8, 2026 | Hull Robert E EVP and COO | Sale | 21,000 | $401.3K |
| Jun 23, 2026 | Callaway Amanda L SVP & Chief Accounting Officer | Sale | 25,767 | $524.9K |
| May 19, 2026 | WOOD DONALD C Director | Award | 6,683 | $135.0K |
| May 19, 2026 | RUFRANO GLENN J Director | Award | 6,683 | $135.0K |
| May 19, 2026 | Bohjalian Thomas N Director | Award | 6,683 | $135.0K |
| May 19, 2026 | HENRY DAVID Director | Award | 6,683 | $135.0K |
| May 19, 2026 | MOORE CONSTANCE B Director | Award | 6,683 | $135.0K |
| Apr 14, 2026 | Scott Peter A President and CEO | Tax withheld | 36,029 | $642.8K |
| Mar 6, 2026 | Bohjalian Thomas N Director | Purchase | 10,000 | $180.9K |
| Mar 4, 2026 | Gabbay Daniel EVP, Chief Financial Officer | Purchase | 10 | $187 |
| Feb 13, 2026 | Crowley Ryan E. EVP and CIO | Tax withheld | 736 | $13.2K |
| Feb 10, 2026 | Hull Robert E EVP and COO | Tax withheld | 4,097 | $71.1K |
| Feb 10, 2026 | Callaway Amanda L SVP & Chief Accounting Officer | Tax withheld | 1,623 | $28.2K |
| Feb 10, 2026 | Scott Peter A President and CEO | Tax withheld | 10,820 | $187.8K |
| Feb 10, 2026 | Crowley Ryan E. EVP and CIO | Tax withheld | 2,905 | $50.4K |
| Feb 10, 2026 | Loope Andrew Edward EVP, General Counsel | Tax withheld | 3,650 | $63.4K |
| Feb 9, 2026 | Gabbay Daniel EVP, Chief Financial Officer | Award | 32,107 | $550.0K |
| Feb 9, 2026 | Scott Peter A President and CEO | Award | 155,867 | $2.67M |
| Feb 9, 2026 | Hull Robert E EVP and COO | Tax withheld | 5,915 | $101.3K |
| Feb 9, 2026 | Crowley Ryan E. EVP and CIO | Award | 32,788 | $561.7K |
| Feb 9, 2026 | Crowley Ryan E. EVP and CIO | Tax withheld | 968 | $16.6K |
| Feb 9, 2026 | Loope Andrew Edward EVP, General Counsel | Award | 32,588 | $558.2K |
| Feb 9, 2026 | Loope Andrew Edward EVP, General Counsel | Tax withheld | 2,924 | $50.1K |
| Feb 9, 2026 | Callaway Amanda L SVP & Chief Accounting Officer | Award | 34,689 | $594.2K |
| Feb 9, 2026 | Callaway Amanda L SVP & Chief Accounting Officer | Tax withheld | 2,769 | $47.4K |
| Feb 9, 2026 | Hull Robert E EVP and COO | Award | 33,859 | $580.0K |
| Jan 12, 2026 | Gabbay Daniel EVP, Chief Financial Officer | Award | 159,051 | $2.75M |
| Jan 3, 2026 | Callaway Amanda L SVP & Chief Accounting Officer | Tax withheld | 2,122 | $36.0K |
| Jan 3, 2026 | Helfrich Austen B. EVP and CFO | Tax withheld | 664 | $11.3K |
| Jan 3, 2026 | Hull Robert E EVP and COO | Tax withheld | 5,244 | $88.9K |
| Jan 3, 2026 | Crowley Ryan E. EVP and CIO | Tax withheld | 1,901 | $32.2K |
| Jan 3, 2026 | Loope Andrew Edward EVP, General Counsel | Tax withheld | 2,275 | $38.6K |
| Jan 1, 2026 | Crowley Ryan E. EVP and CIO | Award | 5,844 | $99.0K |
| Jan 1, 2026 | Scott Peter A President and CEO | Award | 6,640 | $112.5K |
| Dec 31, 2025 | Hull Robert E EVP and COO | Tax withheld | 1,156 | $19.6K |
| Dec 31, 2025 | Crowley Ryan E. EVP and CIO | Tax withheld | 444 | $7.5K |
| Dec 13, 2025 | Hull Robert E EVP and COO | Tax withheld | 5,682 | $97.6K |
| Dec 13, 2025 | Callaway Amanda L SVP & Chief Accounting Officer | Tax withheld | 2,481 | $42.6K |
| Dec 13, 2025 | Crowley Ryan E. EVP and CIO | Tax withheld | 908 | $15.6K |
| Dec 13, 2025 | Loope Andrew Edward EVP, General Counsel | Tax withheld | 2,686 | $46.1K |
| Dec 11, 2025 | Hull Robert E EVP and COO | Tax withheld | 3,614 | $62.7K |
| Dec 4, 2025 | Callaway Amanda L SVP & Chief Accounting Officer | Tax withheld | 992 | $17.3K |
| Sep 5, 2025 | Wilson Julie F. EVP, Chief Admin. Officer | Sale | 15,000 | $270.0K |
| Aug 13, 2025 | Bohjalian Thomas N Director | Purchase | 10,000 | $164.6K |
| Aug 8, 2025 | Wilson Julie F. EVP, Chief Admin. Officer | Tax withheld | 32,058 | $534.4K |
| May 20, 2025 | Leupp Jay P Director | Award | 9,018 | $135.0K |
| May 20, 2025 | WOOD DONALD C Director | Award | 9,018 | $135.0K |
| May 20, 2025 | RUFRANO GLENN J Director | Award | 9,018 | $135.0K |
| May 20, 2025 | Kilroy James Joseph IV Director | Award | 9,018 | $135.0K |
| May 20, 2025 | HENRY DAVID Director | Award | 9,018 | $135.0K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow Healthcare Realty Trust Inc and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading